Pfizer (PFE)

by | Jun 22, 2022 | Daily Trade Alerts

Pfizer (PFE) is technically oversold.

Not only is it sitting at double bottom support dating back to April, it’s also over-extended on RSI, MACD, and Williams’ %R. From a current price of $48.33, we’d like to see it closer to $55.

Helping, the US CDC just recommended the company’s vaccine for children under six. “This expands eligibility for vaccination to nearly 20M additional children and means that all Americans ages six months and older are now eligible for vaccination,” says TheFly.com.

PFE also carries a dividend yield of 3.33% at the moment. In April, its board of directors declared a $0.40 second-quarter 2022 dividend on the company’s common stock, payable June 10, 2022, to holders of the Common Stock of record at the close of business on May 13, 2022.

[sponsor]

The Forever Battery: Making Gas Guzzlers Obsolete

Only 2% of cars sold in the U.S. today are electric vehicles… but that’s about to change — FAST.

A new battery breakthrough is ready to hit the market. It could revolutionize the $2 trillion automotive industry … and could soon make gas guzzlers obsolete.

This technology is predicted to cause a 1,500% surge in electric vehicle sales over the next four years. The company pioneering this new battery could be the investment of a lifetime.

Click here for details.

Sponsored Content